{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:19:56Z","timestamp":1789784396030,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T00:00:00Z","timestamp":1332288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1245\/s10434-012-2256-z","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T14:49:17Z","timestamp":1332254957000},"page":"1723-1731","source":"Crossref","is-referenced-by-count":25,"title":["Hereditary Breast Cancer: Practical Pursuit for Clinical Translation"],"prefix":"10.1245","volume":"19","author":[{"given":"Henry T.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,21]]},"reference":[{"key":"2256_CR1","unstructured":"International Agency for Research on Cancer. Globocan 2008. http:\/\/www-dep.iarc.fr\/ ."},{"key":"2256_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277\u2013300.","journal-title":"CA Cancer J Clin."},{"key":"2256_CR3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","volume":"318","author":"LD Wood","year":"2010","unstructured":"Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2010;318:1108\u201313.","journal-title":"Science."},{"key":"2256_CR4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1101\/gr.6431107","volume":"17","author":"J Lin","year":"2010","unstructured":"Lin J, Gan CM, Zhang X, et al. A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res. 2010;17:1304\u201318.","journal-title":"Genome Res."},{"key":"2256_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","volume":"314","author":"T Sj\u00f6blom","year":"2010","unstructured":"Sj\u00f6blom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2010;314:268\u201374.","journal-title":"Science."},{"key":"2256_CR6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ng2075","volume":"39","author":"DJ Hunter","year":"2007","unstructured":"Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39:870\u20134.","journal-title":"Nat Genet."},{"key":"2256_CR7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM, et al.; the SEARCH Collaborators. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087\u201393.","journal-title":"Nature"},{"key":"2256_CR8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2003.05.096","volume":"21","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, Snyder CL, Lynch JF, Riley BD, Rubinstein WS. Hereditary breast\u2013ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol. 2003;21:740\u201353.","journal-title":"J Clin Oncol."},{"key":"2256_CR9","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMsb042979","volume":"351","author":"AE Guttmacher","year":"2004","unstructured":"Guttmacher AE, Collins FS, Carmona RH. The family history\u2014more important than ever. N Engl J Med. 2004;351:2333\u20136.","journal-title":"N Engl J Med."},{"key":"2256_CR10","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1200\/JCO.2006.10.3119","volume":"25","author":"HT Lynch","year":"2007","unstructured":"Lynch HT, Boland CR, Rodriguez-Bigas MA, Amos C, Lynch JF, Lynch PM. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol. 2007;25:3534\u201342.","journal-title":"J Clin Oncol."},{"key":"2256_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/B978-1-4160-5221-0.00021-8","volume-title":"The breast: comprehensive management of benign and malignant disorders","author":"HT Lynch","year":"2009","unstructured":"Lynch HT, Marcus JN, Lynch J, Snyder CL, Rubinstein WS. Breast cancer genetics: syndromes, genes, pathology, counseling, testing, and treatment. In: Bland KI, Copeland EM III, editors. The breast: comprehensive management of benign and malignant disorders. 4th ed. Philadelphia, PA: Saunders; 2009. p 371\u2013415.","edition":"4"},{"key":"2256_CR12","first-page":"591","volume":"40","author":"P Watson","year":"2003","unstructured":"Watson P, Narod SA, Fodde R, et al. Carrier risk status changes resulting from mutation testing in hereditary nonpolyposis colorectal cancer and hereditary breast\u2013ovarian cancer. J Hum Genet. 2003;40:591\u20136.","journal-title":"J Hum Genet."},{"key":"2256_CR13","first-page":"262","volume-title":"The breast","author":"HT Lynch","year":"1991","unstructured":"Lynch HT, Marcus JN, Watson P, Lynch J. Familial breast cancer, cancer family syndromes, and predisposition to breast neoplasms. In: Bland K, Copeland EM, editors. The breast. Philadelphia: Saunders; 1991. p. 262\u201391."},{"key":"2256_CR14","first-page":"18A","volume":"7","author":"J Marcus","year":"1994","unstructured":"Marcus J, Watson P, Linder-Stephenson L, Conway T, Page D, Lynch H. The pathobiology of BRCA1-linked and -unlinked hereditary breast cancer (HBC) (abstract). Mod Pathol. 1994;7:18A.","journal-title":"Mod Pathol."},{"key":"2256_CR15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/oxfordjournals.aje.a115616","volume":"131","author":"EB Claus","year":"1990","unstructured":"Claus EB, Risch N, Thompson WD, et al. Relationship between breast histopathology and family history of breast cancer. Am J Epidemiol. 1990;131:961\u201372.","journal-title":"Am J Epidemiol."},{"key":"2256_CR16","first-page":"61A","volume":"56","author":"J Marcus","year":"1988","unstructured":"Marcus J, Page D, Watson P, Conway T, Lynch H. High mitotic grade in hereditary breast cancer (abstract). Lab Invest. 1988;56:61A.","journal-title":"Lab Invest."},{"key":"2256_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/1097-0142(19820701)50:1<171::AID-CNCR2820500132>3.0.CO;2-M","volume":"50","author":"PP Rosen","year":"1982","unstructured":"Rosen PP, Lesser ML, Senie MA, Kinne DW. Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer. 1982;50:171\u20139.","journal-title":"Cancer."},{"key":"2256_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00007611-198001000-00012","volume":"73","author":"LS Erdreich","year":"1980","unstructured":"Erdreich LS, Asal NR, Hoge AF. Morphologic types of breast cancer: age, bilaterality, and family history. Southern Med J. 1980;73:28\u201332.","journal-title":"Southern Med J."},{"key":"2256_CR19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/1097-0142(19820501)49:9<1937::AID-CNCR2820490931>3.0.CO;2-H","volume":"49","author":"VA LiVolsi","year":"1982","unstructured":"LiVolsi VA, Kelsey JL, Fischer DB, Holford TR, Mostow ED, Goldenberg IS. Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer. Cancer. 1982;49:1937\u201340.","journal-title":"Cancer."},{"key":"2256_CR20","first-page":"399","volume":"44","author":"H Stalsberg","year":"1989","unstructured":"Stalsberg H, Thomas DB, Noonan EA. The WHO collaborative study of neoplasia and steroid contraceptives. Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. Cancer. 1989;44:399\u2013409.","journal-title":"Cancer."},{"key":"2256_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ajcp\/73.1.25","volume":"73","author":"MD Lagios","year":"1980","unstructured":"Lagios MD, Rose MR, Margolin FR. Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol. 1980;73:25\u201330.","journal-title":"Am J Clin Pathol."},{"key":"2256_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000418692","volume-title":"Hereditary cancer and preventive surgery","author":"S Mosimann","year":"1990","unstructured":"Mosimann S, Torhorst JKH, Weber W, Muller H. Histopathological aspects of familial breast cancer. In: Weber W, Laffer UT, Durig M, editors. Hereditary cancer and preventive surgery. Karger: Basel; 1990. p 1\u20137."},{"key":"2256_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V","volume":"71","author":"EB Claus","year":"1993","unstructured":"Claus EB, Risch N, Thompson WD, Carter D. Relationship between breast histopathology and family history of breast cancer. Cancer. 1993;71:147\u201353.","journal-title":"Cancer."},{"key":"2256_CR24","first-page":"3703","volume":"54","author":"OK Glebov","year":"1994","unstructured":"Glebov OK, McKenzie KE, White CA, Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res. 1994;54:3703\u20139.","journal-title":"Cancer Res."},{"key":"2256_CR25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749\u201353.","journal-title":"Science."},{"key":"2256_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PPO.0b013e3181cf01eb","volume":"16","author":"EA Comen","year":"2010","unstructured":"Comen EA, Robson M. Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Cancer J. 2010;16:48\u201352.","journal-title":"Cancer J."},{"key":"2256_CR27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/GCO.0b013e328334ff57","volume":"22","author":"Y Drew","year":"2010","unstructured":"Drew Y, Plummer R. The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. Curr Opin Obstet Gynecol. 2010;22:67\u201371.","journal-title":"Curr Opin Obstet Gynecol."},{"key":"2256_CR28","doi-asserted-by":"crossref","unstructured":"O\u2019Shaughnessy J, Osborne C, Pippen J, et al. Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine\/carboplatin (G\/C) in patients with metastatic triple-negative breast cancer (TNBC): results of a randomized phase II trial. J Clin Oncol. 2009;27:18s (suppl; abstr 3).","DOI":"10.1200\/jco.2009.27.18s.3"},{"key":"2256_CR29","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbridge LA, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115:2222\u201333.","journal-title":"Cancer."},{"key":"2256_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2353\/jmoldx.2010.090023","volume":"12","author":"KA Mangold","year":"2010","unstructured":"Mangold KA, Wang V, Weissman SM, Rubinstein WS, Kaul KL. Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex\/amplicon size differences. J Mol Diagn. 2010;12:20\u20136.","journal-title":"J Mol Diagn."},{"key":"2256_CR31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. 2006;295:1379\u201388.","journal-title":"JAMA."},{"key":"2256_CR32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O D\u00edez","year":"2003","unstructured":"D\u00edez O, Osorio A, Dur\u00e1n M, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat. 2003;22:301\u201312.","journal-title":"Hum Mutat."},{"key":"2256_CR33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.ejhg.5201091","volume":"12","author":"P Huusko","year":"2004","unstructured":"Huusko P, Juo SH, Gillanders E, et al. Genome-wide scanning for linkage in Finnish breast cancer families. Eur J Hum Genet. 2004;12:98\u2013104.","journal-title":"Eur J Hum Genet."},{"key":"2256_CR34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/gcc.20330","volume":"45","author":"P Smith","year":"2006","unstructured":"Smith P, McGuffog L, Easton DF, et al. A genome wide linkage search for breast cancer susuceptibility genes. Genes Chromosomes Cancer. 2006;45:646\u201355.","journal-title":"Genes Chromosomes Cancer."},{"key":"2256_CR35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMoa0907727","volume":"362","author":"S Wacholder","year":"2010","unstructured":"Wacholder S, Hartge P, Prentice R, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med. 2010;362:986\u201393.","journal-title":"N Engl J Med."},{"key":"2256_CR36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633\u20137.","journal-title":"J Natl Cancer Inst."},{"key":"2256_CR37","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, et al., for The Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346:1616\u201322.","journal-title":"N Engl J Med."},{"key":"2256_CR38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055\u201362.","journal-title":"J Clin Oncol."},{"key":"2256_CR39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304:967\u201375.","journal-title":"JAMA."},{"key":"2256_CR40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/1097-0142(20010215)91:4<625::AID-CNCR1044>3.0.CO;2-4","volume":"91","author":"HT Lynch","year":"2001","unstructured":"Lynch HT. Family information service and hereditary cancer. Cancer. 2001;91:625\u20138.","journal-title":"Cancer."},{"key":"2256_CR41","doi-asserted-by":"crossref","first-page":"55s","DOI":"10.1200\/jco.2006.24.18_suppl.1028","volume":"24","author":"HT Lynch","year":"2006","unstructured":"Lynch HT, Snyder C, Lynch J, Ghate S, Thome S. Family information service (FIS) in a BRCA1 extended family (abstract). J Clin Oncol. 2006;24:55s.","journal-title":"J Clin Oncol."},{"key":"2256_CR42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.6004\/jnccn.2010.0046","volume":"8","author":"DJ MacDonald","year":"2010","unstructured":"MacDonald DJ, Blazer KR, Weitzel JN. Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. J Natl Compr Canc Netw. 2010;8:615\u201324.","journal-title":"J Natl Compr Canc Netw."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2256-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2256-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T14:27:25Z","timestamp":1593872845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,21]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2256"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2256-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,21]]}}}